Exactech: Announced its FDA 510(k) clearance for Vantage Total Ankle, and expects first cases to commence in 2H16
Wright Medical: 2Q16 U.S. total ankle revenue increased +33% vs. 2Q15, partially offset by a continued decline in legacy Tornier foot/ankle systems; anticipated launch date for INVISION revision ankle is now 3Q17—while it isn’t expected to be a “big dollar volume” product, it is expected to drive conversions to total ankle
Integra LifeSciences announced successful completion of initial procedures using the Integra® Cadence™ Total Ankle in Europe.
These initial procedures occurred in close proximity to first U.S. procedures using Cadence.
Exactech: Announced its FDA 510(k) clearance for Vantage Total Ankle, and expects first cases to commence in 2H16
Wright Medical: 2Q16 U.S. total ankle revenue increased +33% vs. 2Q15, partially offset by a continued decline in legacy Tornier foot/ankle systems; anticipated launch date for INVISION revision ankle is now 3Q17—while it isn’t expected to be a “big dollar volume” product, it is expected to drive conversions to total ankle
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
